about
Genome-wide association studies identify four ER negative-specific breast cancer risk lociGenome-wide association study identifies novel breast cancer susceptibility lociPenetrance analysis of the PALB2 c.1592delT founder mutation.Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer diseaseLarge-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repairRefinement of the 22q12-q13 breast cancer--associated region: evidence of TMPRSS6 as a candidate gene in an eastern Finnish populationΓ-secretase components as predictors of breast cancer outcomePALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSLarge-scale genotyping identifies 41 new loci associated with breast cancer risk.Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Crowdsourcing the General Public for Large Scale Molecular Pathology Studies in Cancer.Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p.Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is associated with tumour progression.TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerGenes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility.SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.Transcription factors zeb1, twist and snai1 in breast carcinoma.Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy.Type II transmembrane serine protease gene variants associate with breast cancer.Antenatal gene tests in low-risk pregnancies: molecular screening for aspartylglucosaminuria (AGU) and infantile neuronal ceroid lipofuscinosis (INCL) in Finland.Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progressionIdentification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions.Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls.Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia.The extent of linkage disequilibrium in four populations with distinct demographic histories.Breast-cancer risk in families with mutations in PALB2Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancerParent-of-origin-specific allelic associations among 106 genomic loci for age at menarcheSULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.Genetic variation in mitotic regulatory pathway genes is associated with breast tumor gradeCommon non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association ConsortiumRAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability.
P50
Q24622610-644BD19D-EF4F-401C-8807-60719266F681Q24645441-25E0CB86-5453-4739-8EB9-46B9DE9EA037Q27851443-27B954D9-2762-4438-9BB8-8DBE81A11CEAQ28216782-592AD902-304C-48C0-82BF-76958B069A11Q28267893-D33C2F46-E50C-4341-BDDC-62032A638B4AQ28301674-16C3DE0C-D36D-4C57-9C50-5B095567E866Q28534781-AFF787B2-EA16-4C4A-A6DE-6105213EF6F0Q28584533-45470F5B-51B2-430C-94E5-632955CA58FCQ29416989-539B4CAB-3F6D-4258-B7FD-BD07A7AD3920Q29417100-41692EA9-7E18-4012-B343-84D526220E46Q30000080-DE48D2BA-DCA8-4D91-A9CF-D1A38A91E5E3Q30374367-8A5E8582-04E1-4CE9-AA54-A9FA57B3BD7DQ30660858-91584F2B-B990-4C08-99E0-296E09241344Q31082788-32F05B36-AB95-449F-9E48-AAD39DF1518DQ33197201-8FC773E0-DFED-4B30-BAB8-CCB0B525DBBFQ33330850-F43FA390-A02E-4E00-8E35-4AAA2C38798BQ33495389-22A885DD-9308-4C53-AD78-DD6E2B9AD16BQ33566957-A8A08C61-F9C6-4141-BB17-2647687DAE9CQ33589487-D771D1E4-E6A3-48EE-AE16-4C8D26487292Q33677756-E6943D2E-DEFB-4794-804B-6B9E896E9573Q33735332-BA2554A2-52A2-4A2F-A5E0-48BFDFDF38E5Q33821467-38DEF5F4-F5B1-4C67-8BD6-A0E170295227Q33828680-2CE36FEA-DE92-449B-B772-5C4D86BB9FB6Q33848895-3EB8AAFC-EC26-4804-B5A7-AB0E409B448AQ33910850-A844194E-D3A3-4663-AE2F-C79AD01FA063Q33947477-C3DD7D5E-A374-47A9-967C-8EC167F8BE25Q33990838-F49C2CBB-2E5A-436C-A4D7-D9BAA11642F2Q34038964-26D3951F-E4F7-4DE1-8CDD-23D6736D08BCQ34123806-BEAE3392-4205-45F5-8B66-740AF3343CC0Q34143985-7758590F-9706-48D8-AAA2-D5372E259A6FQ34144358-A7A4F35F-A791-413C-A65E-B05613A5D066Q34148873-1DFC247D-E6CC-4405-AFED-57F14ACDB5B2Q34181322-CACFD422-8226-4292-A59A-77A71AB8C577Q34289136-F8C30BBF-FDC2-44D9-B154-E3CFB58CC664Q34307873-C8ADDA3C-BAF2-4917-BF14-639E8656A056Q34327945-BA4439F6-DF37-4865-A5BB-1798A7B63E98Q34351474-5D608727-1C0B-4AC6-9900-9E222B54135FQ34378972-C1ABBE06-14B2-4894-898E-B9E95981817CQ34379032-F0FEB4E4-5A6F-4124-9B7D-E7E0557AE1D6Q34425705-2E2B1337-46A8-4F0F-881F-D8F39BA5A67C
P50
description
onderzoeker
@nl
name
Arto Mannermaa
@ast
Arto Mannermaa
@en
Arto Mannermaa
@es
Arto Mannermaa
@nl
Arto Mannermaa
@sl
type
label
Arto Mannermaa
@ast
Arto Mannermaa
@en
Arto Mannermaa
@es
Arto Mannermaa
@nl
Arto Mannermaa
@sl
prefLabel
Arto Mannermaa
@ast
Arto Mannermaa
@en
Arto Mannermaa
@es
Arto Mannermaa
@nl
Arto Mannermaa
@sl